Standout Papers
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer (2011)
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer (2015)
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer (2017)
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study (2013)
Immediate Impact
8 by Nobel laureates 20 from Science/Nature 80 standout
Citing Papers
Mechanisms driving the immunoregulatory function of cancer cells
2023 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Works of Mark Benyunes being referenced
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
2015 Standout
Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mark Benyunes | 4461 | 530 | 540 | 1960 | 1459 | 37 | 5.9k | |
| Mark S. Berger | 4535 | 1084 | 730 | 2021 | 1213 | 67 | 6.8k | |
| Cristina Oliva | 4700 | 175 | 575 | 1290 | 1995 | 66 | 6.1k | |
| José Luiz Pedrini | 4021 | 98 | 260 | 1512 | 1404 | 25 | 4.9k | |
| Beth Overmoyer | 4322 | 369 | 410 | 864 | 1250 | 142 | 6.0k | |
| Svetislava J. Vukelja | 4096 | 245 | 353 | 994 | 922 | 82 | 5.1k | |
| Guenther G. Steger | 4434 | 234 | 264 | 1044 | 1433 | 155 | 5.8k | |
| John Gutheil | 2262 | 170 | 396 | 1215 | 809 | 38 | 4.1k | |
| Michaela Lehle | 4082 | 757 | 378 | 1163 | 3979 | 40 | 7.3k | |
| David Miles | 5878 | 105 | 535 | 2655 | 2119 | 92 | 8.2k | |
| Manfred Welslau | 3994 | 186 | 1134 | 1530 | 1413 | 78 | 5.2k |
All Works
Loading papers...